The historical rank and industry rank for Pacira BioSciences's Pretax Margin % or its related term are showing as below:
PCRX'
s Pretax Margin % Range Over the Past 10 Years
Min: -14.82 Med: 0.36 Max: 14.57
Current: 14.57
PCRX's Pretax Margin % is ranked better than 73.31% of 993
companies
in the Drug Manufacturers industry
Industry Median: 4.85
vs PCRX: 14.57
Pacira BioSciences Pretax Margin % Historical Data
The historical data trend for Pacira BioSciences's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pacira BioSciences's Pretax Margin %
For the Drug Manufacturers - Specialty & Generic subindustry, Pacira BioSciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pacira BioSciences's Pretax Margin % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pacira BioSciences's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Pacira BioSciences's Pretax Margin % falls into.
Pacira BioSciences Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
Pacira BioSciences's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Pacira BioSciences Pretax Margin % Related Terms
Thank you for viewing the detailed overview of Pacira BioSciences's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PCRX has been successfully added to your 